References

Uterine and ovarian changes during testosterone administration in young female-to-male transsexuals

10.1016/j.tjog.2016.03.004 · 2016 · External reference

Testosterone therapy for transgender men

10.1016/s2213-8587(16)00036-x · 2017 · External reference

Management of adverse effects in testosterone replacement therapy

10.1590/s1677-5538.ibju.2025.9904 · 2025 · External reference

Recommendations for the diagnosis and treatment of the acute porphyrias

10.7326/0003-4819-142-6-200503150-00010 · 2005 · External reference

Porphyrias

10.1016/s0140-6736(09)61925-5 · 2010 · External reference

The porphyrias: advances in diagnosis and treatment

10.1182/blood-2012-05-423186 · 2012 · External reference

Metabolismo del hemo: las dos caras de los efectos de la acumulación de precursores y porfirinas

2016 · External reference

Heme biosynthesis and the porphyrias

10.1016/j.ymgme.2019.04.008 · 2019 · External reference

Clinical, biochemical, and genetic characterization of acute hepatic porphyrias in a cohort of argentine patients

10.1002/mgg3.1059 · 2021 · External reference

Acute intermittent porphyria in Argentina: an update

10.1155/2015/946387 · 2015 · External reference

Acute intermittent porphyria: predicted pathogenicity of HMBS variants indicates extremely low penetrance of the autosomal dominant disease

10.1002/humu.23067 · 2016 · External reference

Acute hepatic porphyrias

10.1097/j.pbj.0000000000000308 · 2025 · External reference

Porphyrias: pathophysiology and clinical management recommendations for hepatologists

10.1097/hc9.0000000000000822 · 2025 · External reference

Unresolved reference

2026 · External reference

Cytochrome P450 3A4-catalyzed testosterone 6beta-hydroxylation stereochemistry, kinetic deuterium isotope effects, and rate-limiting steps

10.1074/jbc.m501854200 · 2005 · External reference

Porphyria

2003 · External reference

Chapter 56 - Porphyria and its neurologic manifestations

10.1016/b978-0-7020-4087-0.00056-5 · 2014 · External reference

Endocrine treatment of gender-dysphoric/gender-incongruent persons: an endocrine society clinical practice guideline

10.1210/jc.2017-01658 · 2017 · External reference

Hormonal gender reassignment treatment for gender dysphoria

2020 · External reference

Transdermal testosterone delivery: testosterone patch and gel

10.1007/s00345-003-0368-6 · 2003 · External reference

Drug-associated porphyria: a pharmacovigilance study

10.1186/s13023-024-03294-8 · 2024 · External reference

Studies in porphyria: VIII. Relationship of the 5α-reductive metabolism of steroid hormones to clinical expression of the genetic defect in acute intermittent porphyria

10.1016/0002-9343(79)91176-8 · 1979 · External reference

Developmental biology of heme oxygenase

10.1016/s0095-5108(18)30568-2 · 1990 · External reference

Role of heme oxygenase as a modulator of heme-mediated pathways

2019 · External reference

Guidelines for the management of acute porphyria: recommendations from the international Porphyria network

10.1016/s2352-3026(26)00044-x · 2026 · External reference

Evaluation of gonadotropin-releasing hormone agonist treatment for prevention of menstrual-related attacks in acute porphyria

10.3109/00016340903390729 · 2010 · External reference

Acute intermittent porphyria treated by testosterone implant

10.1136/pgmj.68.800.479 · 1992 · External reference

Treatment with assisted reproduction technologies in women with acute hepatic porphyria

10.1111/aogs.14200 · 2021 · External reference

Porphyria cutanea tarda unmasked by supratherapeutic estrogen during gender-affirming hormone therapy

10.1016/j.jdcr.2020.04.036 · 2020 · External reference

Acute variegate Porphyria in a professional bodybuilder after starting a high-protein diet and treatment with testosterone

10.2340/00015555-3769 · 2021 · External reference